These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26773504)

  • 21. TROP2 expression as prognostic marker for gastric carcinoma.
    Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D
    J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma.
    Kobayashi H; Minami Y; Anami Y; Kondou Y; Iijima T; Kano J; Morishita Y; Tsuta K; Hayashi S; Noguchi M
    Virchows Arch; 2010 Jul; 457(1):69-76. PubMed ID: 20473768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MARCH9 Suppresses Lung Adenocarcinoma Progression by Downregulating ICAM-1.
    Shen QM; Wang HY; Xu S
    Cell Physiol Biochem; 2018; 50(1):92-107. PubMed ID: 30278450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of trophoblastic cell surface antigen 2 expression and pathologic parameters in patients with ampullary adenocarcinoma.
    Zhang Y; Wang H; Overman M; Katz MH; Wang H
    Hum Pathol; 2023 Sep; 139():117-125. PubMed ID: 37516386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-associated calcium signal transducer 2 regulates neovascularization of non-small-cell lung cancer via activating ERK1/2 signaling pathway.
    Guo X; Zhu X; Zhao L; Li X; Cheng D; Feng K
    Tumour Biol; 2017 Mar; 39(3):1010428317694324. PubMed ID: 28345466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
    Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
    Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.
    Sawanyawisuth K; Tantapotinan N; Wongkham C; Riggins GJ; Kraiklang R; Wongkham S; Puapairoj A
    Ann Hepatol; 2016; 15(1):71-81. PubMed ID: 26626643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma.
    Kachala SS; Bograd AJ; Villena-Vargas J; Suzuki K; Servais EL; Kadota K; Chou J; Sima CS; Vertes E; Rusch VW; Travis WD; Sadelain M; Adusumilli PS
    Clin Cancer Res; 2014 Feb; 20(4):1020-8. PubMed ID: 24334761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis.
    Tanegashima K; Tanaka Y; Ito T; Oda Y; Nakahara T
    Exp Dermatol; 2024 Oct; 33(10):e15196. PubMed ID: 39422290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.
    Lin JC; Wu YY; Wu JY; Lin TC; Wu CT; Chang YL; Jou YS; Hong TM; Yang PC
    EMBO Mol Med; 2012 Jun; 4(6):472-85. PubMed ID: 22419550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients.
    Chen B; Yang L; Zhang R; Gan Y; Zhang W; Liu D; Chen H; Tang H
    PLoS One; 2017; 12(8):e0182891. PubMed ID: 28792981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of EpCAM and Trop2 in pituitary adenomas.
    Chen X; Pang B; Liang Y; Xu SC; Xin T; Fan HT; Yu YB; Pang Q
    Int J Clin Exp Pathol; 2014; 7(11):7907-14. PubMed ID: 25550831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
    Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
    Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness.
    Yamaguchi Y; Ishii G; Kojima M; Yoh K; Otsuka H; Otaki Y; Aokage K; Yanagi S; Nagai K; Nishiwaki Y; Ochiai A
    J Thorac Oncol; 2010 Sep; 5(9):1361-8. PubMed ID: 20631633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.
    Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Yan W; Liang Z; Xiong H; Chen K
    Tumour Biol; 2015 Sep; 36(10):8085-92. PubMed ID: 25982999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial Splicing Regulatory Protein 1 Inhibits the Invasion and Metastasis of Lung Adenocarcinoma.
    Li L; Qi L; Qu T; Liu C; Cao L; Huang Q; Song W; Yang L; Qi H; Wang Y; Gao B; Guo Y; Sun B; Meng B; Zhang B; Cao W
    Am J Pathol; 2018 Aug; 188(8):1882-1894. PubMed ID: 29803834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
    Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
    J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.